Literature DB >> 5645884

Systemic lupus erythematosus in NZB x NZW hybrid mice treated with the corticosteroid drug betamethasone.

T P Casey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645884

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  6 in total

1.  Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.

Authors:  S Ito; M Ueno; M Arakawa; T Saito; T Aoyagi; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

2.  Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.

Authors:  Y Borel; R M Lewis; J André-Schwartz; B D Stollar; E Diener
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

3.  Suppressed hetergeneous antinuclear antibody response in lymphomabearing NZB/NZW mice.

Authors:  S E Walker; G G Bole
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

4.  Myocardial necrosis and mineralization in normal and Aleutian disease mink fed dexamethasone.

Authors:  L Karstad; H Tabel; D Gordon
Journal:  Can J Comp Med       Date:  1969-10

5.  Thiamphenicol and lupus nephritis. The effects of long-term therapy on kidney function and pathology: a pilot study.

Authors:  L O Simpson; I Aarons; J B Howie
Journal:  Br J Exp Pathol       Date:  1979-02

6.  Micelle-Forming Dexamethasone Prodrug Attenuates Nephritis in Lupus-Prone Mice without Apparent Glucocorticoid Side Effects.

Authors:  Zhenshan Jia; Xiaobei Wang; Xin Wei; Gang Zhao; Kirk W Foster; Fang Qiu; Yangyang Gao; Fang Yuan; Fang Yu; Geoffrey M Thiele; Tatiana K Bronich; James R O'Dell; Dong Wang
Journal:  ACS Nano       Date:  2018-07-17       Impact factor: 15.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.